- Home
- VIVK vs GRCE Comparison
VIVK vs GRCE Comparison
Compare VIVK & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- GRCE
- Stock Information
- Founded
- VIVK 2006
- GRCE 2002
- Country
- VIVK United States
- GRCE United States
- Employees
- VIVK N/A
- GRCE N/A
- Industry
- VIVK Oilfield Services/Equipment
- GRCE
- Sector
- VIVK Energy
- GRCE
- Exchange
- VIVK Nasdaq
- GRCE NYSE
- Market Cap
- VIVK 34.9M
- GRCE 40.0M
- IPO Year
- VIVK N/A
- GRCE N/A
- Fundamental
- Price
- VIVK $0.84
- GRCE $2.86
- Analyst Decision
- VIVK
- GRCE Strong Buy
- Analyst Count
- VIVK 0
- GRCE 1
- Target Price
- VIVK N/A
- GRCE $12.00
- AVG Volume (30 Days)
- VIVK 1.7M
- GRCE 25.7K
- Earning Date
- VIVK 05-20-2025
- GRCE 06-10-2025
- Dividend Yield
- VIVK N/A
- GRCE N/A
- EPS Growth
- VIVK N/A
- GRCE N/A
- EPS
- VIVK N/A
- GRCE N/A
- Revenue
- VIVK $111,130,140.00
- GRCE N/A
- Revenue This Year
- VIVK N/A
- GRCE N/A
- Revenue Next Year
- VIVK N/A
- GRCE N/A
- P/E Ratio
- VIVK N/A
- GRCE N/A
- Revenue Growth
- VIVK 85.84
- GRCE N/A
- 52 Week Low
- VIVK $0.55
- GRCE $1.75
- 52 Week High
- VIVK $3.45
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- VIVK 58.19
- GRCE N/A
- Support Level
- VIVK $0.71
- GRCE N/A
- Resistance Level
- VIVK $1.27
- GRCE N/A
- Average True Range (ATR)
- VIVK 0.09
- GRCE 0.00
- MACD
- VIVK 0.03
- GRCE 0.00
- Stochastic Oscillator
- VIVK 51.22
- GRCE 0.00
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.